# Carlsmed, Inc. (CARL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CARL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 35.06M | $ -19.21M | $ -20.57M | $ 21.92M | $ 84.25M |
| 2025 | $ 51.72M | $ -30.34M | $ -30.33M | $ 17.41M | $ 98.87M |
| 2024 | $ 28.55M | $ -25.50M | $ -26.96M | $ 17.18M | $ -70.63M |
| 2023 | $ 4.69M | $ -5.99M | N/A | $ 11.39M | $ -2.75M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.26 |
| Liabilities / Eq | 0.40 |
| Current Ratio | 8.84 |

## Other views

- [Metrics](https://sponda.capital/en/CARL.md)
- [Charts](https://sponda.capital/en/CARL/charts.md)
- [Compare](https://sponda.capital/en/CARL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.